Stock Market Outlook

An insider is legally permitted to buy and sell shares of the firm – and any subsidiaries – that employs him or her. However, these transactions must be properly registered with the Securities and Exchange Commission (SEC) and are done with advance filings. You can find details of this type of insider trading on the SEC’s EDGAR database. This algorithmic forecast is for stocks with recently reported insiders’ transactions.An “insider” is any person who possesses at least one of the following:

• access to valuable non-public information about a corporation (for example a company’s directors and high-level executives)
• ownership of more than 10% of the company’s equity

Package Name: Insiders Stocks
Recommended Positions: Long
Forecast Length: 7 Days (11/14/2017 – 11/21/2017)
I Know First Average: 6.18%

I Know First’s State of the Art Algorithm accurately forecasted 7 out of 10 trades in this Insiders Stocks Package for the 7 Days time period. The greatest return came from NKTR at 34.72%. NPTN and VRTU also performed well for this time horizon with returns of 17.00% and 6.99%, respectively. The package itself saw an overall return of 6.18%, providing investors with a 5.63% premium above the S&P 500’s return of 0.55% for the same time period.

Nektar Therapeutics (NKTR), develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. Its product pipeline includes drug candidates in therapeutic areas comprising cancer, auto-immune disease, and chronic pain.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.